FGF21 and Parkinson disease: Spontaneous locomotor activity was evaluated in the open field test, which is controlled by the nigrostriatal pathway (Figure 1B)24; FGF21 treatment significantly improved the total distance traveled in the open field compared with untreated PD mice (p < 0.001, Figure 1C).